Axiom Investment Management’s AstraZeneca AZN Stock Holding History

Axiom Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Buy	557 +61	+12%	+$11.5K	0.07%	155
2026 Q1	$97.8K	Buy	+496	New	+$95.6K	0.07%	148
2022 Q4	–	Sell	-150	Closed	-$15K	–	116
2022 Q3	$15K	Buy	+150	New	+$19K	0.03%	235
2019 Q3	–	Sell	-3,624	Closed	-$298K	–	231
2019 Q2	$298K	Buy	3,624 +49	+1%	+$3.84K	0.05%	290
2019 Q1	$287K	Sell	3,575 -957	-21%	-$75.4K	0.05%	294
2018 Q4	$344K	Buy	+4,532	New	+$354K	0.07%	242

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Axiom Investment Management's AZN Position: Q2 2026 in Review

Axiom Investment Management increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $11.5K and bringing the position to 557 shares worth $106K. The position accounts for 0.07% of the portfolio, ranked #155.

Axiom Investment Management first reported a position in AZN in Q4 2018 and has held it in 6 quarters since. The position peaked at $344K in Q4 2018. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Axiom Investment Management held 557 shares of AstraZeneca worth $106K as of Q2 2026.
Axiom Investment Management bought 61 AstraZeneca shares in Q2 2026, an estimated $11.5K.
AstraZeneca made up 0.07% of Axiom Investment Management's portfolio in Q2 2026, its #155 holding.
Axiom Investment Management first reported a position in AstraZeneca in Q4 2018 and has held it in 6 quarters since.
Axiom Investment Management's AstraZeneca position peaked at $344K in Q4 2018.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.